Commercialization for SBIR/STTR
February 22 @ 10:00 am - 11:30 am EST
Commercialization plans can be a key differentiator in the SBIR/STTR programs, so it is important to know what the agencies are looking for and how to go about developing a good plan. This session will review the requirements and guide you through where to start, what to include, and how to show your best self.
- Agency expectations for commercialization plans in your Phase I & II projects
- Where to find cost-effective market research
- What to include in your financial plan and revenue stream
- What quality “support & commitment letters” are and more!
ABOUT THE PRESENTER:
Megan Varnum, Ph.D.
Megan joined BBCetc as a Principal Consultant in 2019 with a wealth of experience in leading biological technologies on the path to commercialization. As CEO of FibrosIX Inc., a Michigan company developing compounds for the treatment or prevention of fibrosis-related disorders, Megan was involved in all aspects of planning and operation of the company. This included writing an SBIR grant proposal, which was awarded from the National Cancer Institute. Her prior experience includes serving as an Entrepreneur in Residence for Michigan State University’s Spartan Innovations where she assisted MSU researchers in translating their technologies into startup businesses. While at MSU, she managed the launch of two startups and assisted in the preparation of both NIH and NSF SBIR proposals. A former Research Associate of the Scripps Research Institute, Megan received a B.S degree from the University of Massachusetts Amherst and a PhD from Boston University.